On this page
- Published edition and draft distinction
- Match the claim to the evidence subject
- Review product information before approving artwork
- Questions for the supplier file
- A fictional private-label decision
- Buy the published biological-evaluation document
- Common buying questions
- Explore more standards buying guides
Published edition and draft distinction
Genorma lists EN 455-3:2023 as published, with the 2015 edition identified as withdrawn. The EVS catalogue confirms the 2023 reference. Genorma also identifies amendment work in development. A draft amendment is not a published amendment to include automatically in the order.
The public scope concerns evaluation of biological safety for single-use medical gloves, together with labelling and information relevant to the methods used. Ask the technical reviewer to identify the appropriate published reference and complete assessment set. This guide does not reproduce test methods or determine an individual's sensitivity to a glove.
Match the claim to the evidence subject
| Supplier information | What it can help explain | Question that remains |
|---|---|---|
| Material description | Identifies a construction material. | What product-specific biological evidence supports the offered glove? |
| Laboratory report | Provides findings for identified samples and a stated subject. | Does it represent the ordered model and relevant processing state? |
| Manufacturer information | Explains claims, instructions and limitations. | Is it consistent with the model and evidence in the purchasing file? |
| Private-label artwork | Communicates the offered product to the customer. | Who verifies that the claims correspond to the supporting evidence? |
Begin with a clear product schedule. Identify the glove model, material and construction options, whether different supplied versions are involved, and the manufacturer responsible for the evidence. Ask the supplier to explain how the available reports relate to those versions. Keep the explanation with the accepted offer, so subsequent buyers do not have to reconstruct the relationship from a brand name.
Do not treat a broad material category as a universal assurance about reactions. If a quotation uses a claim about a constituent, residue or other biological subject, ask what the claim means and what evidence supports it. Have the qualified reviewer assess the wording and evidence together. This guide does not recommend a glove to anyone with an allergy or provide advice on managing a reaction.
Review product information before approving artwork
A private-label programme introduces a useful division of responsibilities. The commercial team may approve the brand and visual presentation, while the technical reviewer checks the claims against the exact manufacturer's product and evidence. Agree who performs that review before packaging is ordered. Otherwise, the printed claim can become fixed before its supporting information has been examined.
Ask whether the supplier's information and reports describe the same model and version. Different documents can be accurate individually while leaving an unresolved relationship between them. An assessment report with one product code and a label with another should have a documented connection, particularly when the distributor uses its own code.
Keep biological evidence separate from physical performance and freedom-from-holes information. The medical-glove family guide helps compare the different subjects. The responsible reviewer should select the complete document set for the product; one Part 3 report is not a complete approval of every medical-glove characteristic or regulatory requirement.
Questions for the supplier file
- Which model and supplied versions does the biological-evaluation evidence represent?
- Does the information connect the manufacturer's identifiers to any distributor or private-label codes?
- Which published reference and edition were used in the offered assessment?
- What product claims and limitations need technical approval before artwork is released?
- Who reviews changes in formulation, processing, packaging claims or the underlying manufacturer?
A fictional private-label decision
A distributor prepares packaging for a new private-label examination glove. The artwork uses a broad biological-safety assurance copied from an earlier product's sales sheet. The manufacturer's reports use a different model code, and the distributor's purchasing file does not explain the relationship.
The buyer requests the exact model mapping and asks the technical reviewer to examine the proposed wording against the available evidence. Commercial artwork approval waits for that defined review. The fictional decision is to make the claim and product identity traceable; it does not conclude that either glove is safe for a particular user or clinical task.
Buy the published biological-evaluation document
Check the publication status, seller's language, document licence, format and checkout terms.
Common buying questions
Does Part 3 replace physical-properties evidence?
No. The different subjects should be identified separately in the product review.
Does a material name settle the biological question?
No. Ask the qualified reviewer to assess the exact product and relevant evidence, including the proposed claims.
Should an amendment draft be treated as current?
Check the lifecycle. Development work and a published amendment are different document statuses.
Public catalogue sources checked on 7 October 2026. Regulatory applicability and product acceptance require their own responsible review.
Explore more standards buying guides
Browse standards by reference and subject to compare related document choices.